RIBOZYME AND OMICS
Targeting dominant mutations to lower mutant : WT
Targeted expressing cell-specific WT protein expression
Possible to maintain endogenous gene expression level
Possible to target all Ad RP mutations with one therapy
Mutant removal and WT protein expression
No use of endogenous cell machinery
No need of extra protein introduction/expression